BRAIN Biotech AG
XETRA:BNN
BRAIN Biotech AG
XETRA:BNN
Price:
2.82 EUR
0.71%
Updated:
May 3, 2024
BRAIN Biotech AG
EPS (Diluted)
|
BRAIN Biotech AG
EPS (Diluted) Peer Comparison
Comparables:
WCH
EVK
1COV
ACT
SY1
Competitive EPS (Diluted) Analysis
Latest Figures & CAGR of Competitors
Latest Figures & CAGR of Competitors
| Company | EPS (Diluted) | CAGR 3Y | CAGR 5Y | CAGR 10Y | |
|---|---|---|---|---|---|
|
|
BRAIN Biotech AG
XETRA:BNN
|
EPS (Diluted)
€0
|
CAGR 3-Years
13%
|
CAGR 5-Years
5%
|
CAGR 10-Years
N/A
|
|
|
Wacker Chemie AG
XETRA:WCH
|
EPS (Diluted)
€6
|
CAGR 3-Years
18%
|
CAGR 5-Years
5%
|
CAGR 10-Years
66%
|
|
|
Evonik Industries AG
XETRA:EVK
|
EPS (Diluted)
-€1
|
CAGR 3-Years
N/A
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
|
|
Covestro AG
XETRA:1COV
|
EPS (Diluted)
-€1
|
CAGR 3-Years
N/A
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
|
|
AlzChem Group AG
XETRA:ACT
|
EPS (Diluted)
€3
|
CAGR 3-Years
21%
|
CAGR 5-Years
39%
|
CAGR 10-Years
N/A
|
|
|
Symrise AG
XETRA:SY1
|
EPS (Diluted)
€2
|
CAGR 3-Years
3%
|
CAGR 5-Years
3%
|
CAGR 10-Years
6%
|
See Also
What is BRAIN Biotech AG's EPS (Diluted)?
EPS (Diluted)
-0.4
EUR
-0.4
EUR
Based on the financial report for Dec 31, 2023, BRAIN Biotech AG's EPS (Diluted) amounts to -0.4 EUR.
What is BRAIN Biotech AG's EPS (Diluted) growth rate?
EPS (Diluted) CAGR 5Y
5%
5%
Over the last year, the EPS (Diluted) growth was -23%. The average annual EPS (Diluted) growth rates for BRAIN Biotech AG have been 13% over the past three years , 5% over the past five years .
You don't have any saved screeners yet
